Turn Therapeutics (TTRX) announces that its common stock is scheduled to commence trading, October 8, 2025, on the Nasdaq Capital Market under ticker symbol “TTRX.” The Company’s registration statement on Form S-1 was declared effective by the U.S. Securities and Exchange Commission September 30, 2025. Clear Street served as financial advisor to the company. Davis, Polk, and Wardwell acted as legal counsel.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.